Related Experiment Video

Updated: Aug 21, 2026

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
05:18

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters

Published on: July 12, 2024

Fine particulate matter and wheezing illnesses in the first year of life

Paulina Pino1, Tomas Walter, Manuel Oyarzun

  • 1Facultad de Medicina, Universidad de Chile, Santiago, Chile. ppino@med.uchile.cl

Epidemiology (Cambridge, Mass.)
|October 12, 2004
PubMed

Insights

Fine particulate matter (PM2.5) exposure increases infant wheezing bronchitis risk. This air pollution may impact long-term respiratory health, especially in vulnerable infants.

Area of Science:

  • Environmental Health
  • Pediatric Respiratory Medicine
  • Epidemiology

Background:

  • Fine particulate matter (PM2.5), primarily from vehicle exhaust, is linked to mortality and morbidity.
  • Limited data exist on PM2.5's impact on infant respiratory illnesses.

Purpose of the Study:

  • To investigate the association between PM2.5 exposure and respiratory illnesses in infants.
  • To assess the impact of air pollutants like PM2.5, SO2, and NO2 on infant respiratory health.

Main Methods:

  • A cohort study of 504 infants followed for their first year of life.
  • Collected air pollution data (PM2.5, SO2, NO2) from a governmental monitoring network.
  • Analyzed respiratory diagnoses, adjusting for covariates like socioeconomic status and family history.

Main Results:

  • Wheezing bronchitis was the most frequent diagnosis.
  • A 10 microg/m³ increase in daily average PM2.5 correlated with a 5% increased risk of wheezing bronchitis (1-day lag).
  • The PM2.5 association was stronger with a 9-day lag and in infants with a family history of asthma.

Conclusions:

  • Air pollution, specifically PM2.5 from vehicular exhaust, negatively affects infant respiratory health.
  • Potential for chronic respiratory effects later in life exists.
  • Further research into long-term impacts is warranted.
Abstract

More Related Videos

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma